Market Place
Sourcing Support
FDA Grants Fast Track Designation For Biomarker-Guided DB104
09 Oct 2024 //
PR NEWSWIRE
Denovo Biopharma: Positive Phase 2b Depression Data For DB104 At ASCP
28 May 2024 //
PR NEWSWIRE
CIRM Grants $11.8M For Glioblastoma Gene Therapy Trial
30 Apr 2024 //
PR NEWSWIRE
Denovo Announces a Major Breakthrough in Treatment-Resistant Depression
03 Apr 2024 //
PR NEWSWIRE
Denovo Biopharma Creates Innovative Gene Registry Program
06 Mar 2023 //
PR NEWSWIRE
First Patient Dosed in the ENLIGHTEN Biomarker-Guided Trial of DB104
28 Jul 2022 //
PRNEWSWIRE
FDA Approves Denovo`s IND to Initiate First Biomarker-Guided Global CNS Trial
31 Jan 2022 //
PRNEWSWIRE
Denovo Announces Breakthrough Discovery of a Novel Genetic Biomarker for DB107
16 Dec 2021 //
PRNEWSWIRE
Denovo Announces Breakthrough Discovery of DB107 for Gene Therapy-Based Medicine
16 Dec 2021 //
PRNEWSWIRE
Denovo Biopharma Announces Partner Aytu BioPharma Receives FDA Clearance
14 Dec 2021 //
BENZINGA
FDA Approves & Grants ODD to Aytu`s Enzastaurin in VEDS
14 Dec 2021 //
PRNEWSWIRE
QIAGEN, Denovo Biopharma Partner to Develop Companion Diagnostic Test for DLBCL
09 Dec 2021 //
BUSINESSWIRE
Denovo Biopharma LLC Announces Multiple Presentations at Major Conferences
02 Nov 2021 //
PRNEWSWIRE
Denovo Biopharma In-Licenses Late-Stage Alzheimer`s Disease Asset from Lundbeck
01 Jul 2021 //
PR NEWSWIRE
Denovo`s Licenses DB102 for Rare Genetic Pediatric Onset Disorders to Aytu
14 Apr 2021 //
BIOSACE
Denovo`s Licenses DB102 (Enzastaurin) for Rare Genetic Pediatric Onset
13 Apr 2021 //
PRNEWSWIRE
Denovo Biopharma Acquires a Novel Late-Stage Oncology Drug and Expands
10 Dec 2020 //
PRNEWSWIRE
Denovo closes $46M series D to advance PKC-beta inhibitor in phIII studies
15 Oct 2020 //
BIOWORLD
FDA Grants Fast Track Designation For DB102 in Patients with Newly-Diagnosed GBM
17 Jul 2020 //
PRNEWSWIRE
Denovo Biopharma To Acquire Tocagen`s Entire Replicating Gene Therapy
28 Apr 2020 //
PR NEWSWIRE
Denovo Biopharma Announces Breakthrough Discovery of DB104 (Liafensine)
12 Mar 2020 //
YAHOO
Denovo Biopharma Enters into Option Agreement with Rumpus Therapeutics
21 Jan 2020 //
STREET INSIDER
Denovo Biopharma Licenses Global Rights to a Novel Late-Stage Oncology Drug
06 Dec 2019 //
PR NEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.